| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.34 | 0.007 |